10202017Headline:

Single-cell Analysis Market by Product, Cell Type, Technique, Application & End User – Global Forecasts to 2022

The single-cell analysis market is expected to reach USD 3.59 billion by 2022 from USD 1.65 billion in 2017, at a CAGR of 16.5%.The market is witnessing growth due to technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases are the major factors driving the growth of the single-cell analysis market.

However, the high cost of single-cell analysis instruments may restrain the growth of this market. The high growth potential of single-cell sequencing (SCS) and integration of microfluidics in single-cell analysis are some of the major factors that are expected to offer growth opportunities for market players in the coming years. The survival of small players and new entrants is a major challenge in the market.

Download PDF Brochurehttp://www.marketsandmarkets.com/pdfdownload.asp?id=171955254

Based on product, the market is segmented into consumables and instruments. In 2017, consumables segment is expected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the requirement of frequent and repeat purchase of these products as compared to instruments, which are considered as a one-time investment.

Based on cell type, the market is segmented into human, animal, and microbial cells. Among these, the animal cells segment is expected to register the highest CAGR during the forecast period. The growing pharmaceutical industry and rising investments in animal cell research are expected to drive the growth of this segment.

On the basis of technique, the single-cell analysis market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques (including single-molecule fluorescence in situ hybridization, micromanipulation, and automated capillary electrophoresis). The NGS segment is expected to register the highest growth rate during the forecast period. The advances in NGS techniques, as well as the introduction of advanced microfluidic devices, are the major factors contributing to the growth of this segment.

On the basis of application, the market is segmented into research and medical applications. Research application segment accounted for the largest share of the single-cell analysis market. This segment is also expected to register the highest CAGR during the forecast period. The technological advancements, as well as increasing demand for life science research, are the major factors contributing to the growth of this segment.

On the basis of end user, the market is segmented into academic & research laboratories, hospitals & diagnostic laboratories, cell banks & IVF centers, and biotechnology & pharmaceutical companies. The biotechnology & pharmaceutical companies are expected to register the highest CAGR during the forecast period. The increasing number of R&D activities undertaken by these companies for the development of novel products is a key factor driving the growth of this segment.

Among the four regional segment covered in the single-cell analysis market—North America, Europe, Asia, and Rest of the World (RoW)—Asia is expected to register the highest CAGR during the forecast period. Factors such as the large population in China and India, rising geriatric population, and increasing incidence of chronic diseases are supporting the growth of the single-cell analysis market in Asia.

What Next?

Recent Articles